Sciabica, S.; Barbari, R.; Fontana, R.; Tafuro, G.; Semenzato, A.; Traini, D.; Silva, D.M.; Reis, L.G.D.; Canilli, L.; Terno, M.;
et al. A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties. Pharmaceuticals 2023, 16, 431.
https://doi.org/10.3390/ph16030431
AMA Style
Sciabica S, Barbari R, Fontana R, Tafuro G, Semenzato A, Traini D, Silva DM, Reis LGD, Canilli L, Terno M,
et al. A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties. Pharmaceuticals. 2023; 16(3):431.
https://doi.org/10.3390/ph16030431
Chicago/Turabian Style
Sciabica, Sabrina, Riccardo Barbari, Riccardo Fontana, Giovanni Tafuro, Alessandra Semenzato, Daniela Traini, Dina M. Silva, Larissa Gomes Dos Reis, Luisa Canilli, Massimo Terno,
and et al. 2023. "A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties" Pharmaceuticals 16, no. 3: 431.
https://doi.org/10.3390/ph16030431
APA Style
Sciabica, S., Barbari, R., Fontana, R., Tafuro, G., Semenzato, A., Traini, D., Silva, D. M., Reis, L. G. D., Canilli, L., Terno, M., Marconi, P., Baldisserotto, A., Vertuani, S., & Manfredini, S.
(2023). A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties. Pharmaceuticals, 16(3), 431.
https://doi.org/10.3390/ph16030431
